Seth Rudnick - Jun 29, 2021 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Director
Signature
/s/ James Stillman Hanson, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Jun 29, 2021
Transactions value $
-$219,760
Form type
4
Date filed
6/30/2021, 04:05 PM
Previous filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Options Exercise $3.11K +7.97K +181.57% $0.39* 12.4K Jun 29, 2021 Direct
transaction GTHX Common Stock Options Exercise $609 +2.03K +16.43% $0.30* 14.4K Jun 29, 2021 Direct
transaction GTHX Common Stock Sale -$223K -10K -69.5% $22.35* 4.39K Jun 29, 2021 Direct F1, F2, F3
holding GTHX Common Stock 5.27K Jun 29, 2021 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Option (Right to Buy) Options Exercise $0 -2.03K -14.62% $0.00 11.9K Jun 29, 2021 Common Stock 2.03K $0.30 Direct F5
transaction GTHX Stock Options (Right to Buy) Options Exercise $0 -7.97K -100% $0.00* 0 Jun 29, 2021 Common Stock 7.97K $0.39 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 The price represents the weighted average price with a low of $22.11 and a high of $22.58. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
F3 Represents 4,389 restricted stock units
F4 These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F5 All shares underlying this option have vested.